DEVELOPMENT OF A NOVEL TUMOR-TARGETING AND TUMOR-PENETRATING NANOSYSTEM FOR BREAST CANCER THERAPY

$1,412,302FY2020Defense Health AgencyDOD

Endurx Pharmaceuticals Inc

Investigators